In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reviving Cardiac Science

Executive Summary

Both physicians and the general public share the perception that a sudden cardiac emergency in a hospital will, almost instantly, draw a response team equipped with a crash cart to revive the patient. Recent studies show, however, that average response times can be as high as ten minutes in situations where each minute that passes diminishes the patient's survival rate by 10%. Cardiac Science's technology continuously monitors patients, detects a rhythm problem and delivers defibrillation shocks to return the patient to normal rhythm in an average response time of 21 seconds. Some physicians, however, remain skeptical about the need for such technology, presenting the company with the challenge of convincing clinicians to alter longstanding practice patterns.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

IV001494

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel